Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04305093 · ClinicalTrials.gov registry record
Data Mining: Precision Analytical Retrospective Data Correlation
A clinical trial of Hormone Disturbance and Obesity; Endocrine, sponsored by Precision Analytical.
- Completed
- Registry status
- 144,561
- Enrollment target
- 1
- Study location
NCT04305093: Completed study of Hormone Disturbance and Obesity; Endocrine, sponsored by Precision Analytical.
NCT04305093 is a study of Hormone Disturbance and Obesity; Endocrine that has completed, run by Precision Analytical. The registered enrollment target is 144,561 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04305093, a study of Hormone Disturbance and Obesity; Endocrine, has completed, sponsored by Precision Analytical.
- COMPLETED
- Registry status
- 144,561 participants
- Enrollment target
- 1
- Study location
Study Summary
Data from previously analyzed clinical samples tested by Precision Analytical, Inc. will be mined to identify and select samples from patients reporting hormone supplement use. Patient demographics (BMI, for example), different therapies and expected changes in hormone levels will be analyzed and hormone metabolite patterns will be compared. Samples will be deidentified prior to analysis.
Primary Outcome
Relationship of BMI to cortisol production and clearance
Conditions Studied
Study Locations (1)
Oregon
- Precision Analytical, Inc - McMinnville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144,561 participants |
| Start Date | 2019-12-15 |
| Est. Completion | 2023-03-28 |
What the finished NCT04305093 record still lists
NCT04305093 is an observational study that tracks outcomes without assigning an intervention. Its 144,561 participants enrollment target places it among the larger protocols in the corpus.
The record links to 2 conditions, with Hormone Disturbance appearing as the primary indexed condition, and to 0 interventions.
NCT04305093 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT04305093 about?
NCT04305093 is a clinical study titled "Data Mining: Precision Analytical Retrospective Data Correlation". Data from previously analyzed clinical samples tested by Precision Analytical, Inc. will be mined to identify and select samples from patients reporting hormone supplement use. Patient demographics (BMI, for example), different therapies and expected changes in hormone levels will be analyzed and ho...
What is the current status of trial NCT04305093?
This trial is currently completed. The enrollment target is 144,561 participants. The study started on 2019-12-15. Estimated completion is 2023-03-28.
What conditions does trial NCT04305093 study?
This clinical trial studies the following conditions: Hormone Disturbance, Obesity; Endocrine.
Who is sponsoring clinical trial NCT04305093?
This trial is sponsored by Precision Analytical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04305093 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hormone Disturbance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI